Share Share this content Opens in a new window Opens in a new window Opens in a new window Opens in a new window OPA's Response to Consultation on Reducing Regulatory Burdens on Pharmacies You may be interested in Smoke Free Ontario Modernization October 29, 2020 Post category: Advocacy Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Advocacy OPA Vaccine Access Action Plan December 10, 2025 Post category: Advocacy Nirmatrelvir/Ritonavir (Paxlovid) Prescribing December 12, 2022 Post category: Advocacy
Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Advocacy
